Coming from this article (HN comments):

https://news.cornell.edu/stories/2025/12/ozempic-changing-foods-americans-buy

Ozempic is changing the foods Americans buy

Within six months of starting a GLP-1 medication, households reduce grocery spending by an average of 5.3%. Among higher-income households, the drop is even steeper, at more than 8%. Spending at fast-food restaurants, coffee shops and other limited-service eateries falls by about 8%.

That seems huge to me. There’s lots of memes about bad food practices in the US and there’s a lot of truth to it. In 10 years, will there be a stereotype of Americans as skinny people that don’t eat much?

I don’t have a link but I’ve seen that companies are pushing back on this, like researching how to make drinks that counteract GLP-1 drugs. Will Big Pharma or Big Sugar win out?

Image source, semaglutide molecule

  • m_‮f@discuss.onlineOPM
    link
    fedilink
    English
    arrow-up
    7
    ·
    2 months ago

    Huh, just discovered that it’s now generic in Canada

    Semaglutide’s patent protection expired in Canada at the beginning of 2026. (Novo Nordisk failed to pay a required patent maintenance fee.)

    My understanding is that it’ll be generic in the US soon too, and any improvements are just in delivery methods (pill vs injection). I’d agree that if it is able to be locked behind expensive patents that there might not be much societal change, but if you assume that it’s as easy to get as tylenol or something, that seems big.

    • SaveTheTuaHawk@lemmy.ca
      link
      fedilink
      English
      arrow-up
      4
      ·
      2 months ago

      (Novo Nordisk failed to pay a required patent maintenance fee.)

      About $400. They killed off $8B in income. Someone needs to see HR.